Tom Pickles¹, S. Larry Goldenberg², Gary Steinhoff¹

Canadian Journal of Urology, Vol.12, No.2, pp. 2593-2597, 2005

Abstract Introduction and objective: High-Intensity Focused Ultrasound (HIFU) is a technology that has moved from being used for benign prostate disease to the treatment of prostate cancer. A technology review was undertaken to guide patients and physicians as to its suitability.
Method: An evidence-based review of published papers in the English language, with additional material from internet and other sources.
Results and conclusions: Only case series have been published; there are no randomized studies. The quality of evidence is poor, with no reports having longer follow-up than a mean of 2 years, with median follow-ups substantially shorter. Efficacy outcomes are More >

Luc Valiquette, Francesco Montorsi, Wayne J. G. Hellstrom, François Giuliano, Martin Homering, Terry Taylor, Ian Eardley

Canadian Journal of Urology, Vol.12, No.3, pp. 2699-2699, 2005

Abstract This article has no abstract. More >

Tom Pickles, S. Larry Goldenberg, Gary Steinhoff

Canadian Journal of Urology, Vol.12, No.3, pp. 2684-2686, 2005

Abstract This article has no abstract. More >

Saleh Binsaleh, Roman Jednak, Joao Luiz Pippi-Salle

Canadian Journal of Urology, Vol.12, No.3, pp. 2724-2725, 2005

Abstract We report the case of a neonate who underwent bladder exstrophy repair on the second day of life. Bilateral ureteral stents were placed intraoperatively. Postoperatively azotemia developed secondary to kinking of the proximal ureter bilaterally. Issues in diagnosis and management are discussed. More >

Jason Evans, Milton W. Datta, Mary Goolsby, Peter Langenstroer

Canadian Journal of Urology, Vol.12, No.3, pp. 2722-2723, 2005

Abstract Eccrine porocarcinoma, an uncommon carcinoma of the sweat glands, rarely arises from the male genitalia. In past reports this presentation has been associated with Paget’s disease. This is the first known report of eccrine porocarcinoma of the scrotum unassociated with Paget’s disease. More >

A. H. Feifer, B. C. Fong, L. Feldman, G. Fried, L. A. Stein, P. Metrakos, S. Bergman, M. Anidjar

Canadian Journal of Urology, Vol.12, No.3, pp. 2713-2721, 2005

Abstract Objective: To assess the efficacy of CT angiography (CTA) in evaluating the renovascular anatomy in 50 patients who underwent laparoscopic donor nephrectomy, and to correlate results with donor morbidity and recipient outcome.
Methods: Forty-eight patients were evaluated by CTA prior to laparoscopy. Donors with aberrant renovasculature and their respective recipients were divided into: 1) accurate preoperative CTA ("predictive group", PG), 2) inaccurate CTA ("non-predictive group", NPG). Warm ischemia times (WIT), estimated blood loss (EBL), operative time (OT), and the open conversion rate were compared. Recipient creatinine values on post-operative day 1 and 3 months were recorded with… More >

Neil T. Dwyer, Thomas F. Whelan

Canadian Journal of Urology, Vol.12, No.3, pp. 2710-2712, 2005

Abstract Splenosis should be considered in the differential of any patient with a history of splenic trauma or removal and a solid enhancing mass near or within the kidney. Splenosis is the autotransplantation of splenic tissue associated with splenic trauma or surgery, and can be diagnosed properatively, avoiding unnecessary surgery. More >

Howard H. Pai^1,2, Francis Lau²

Canadian Journal of Urology, Vol.12, No.3, pp. 2700-2709, 2005

Abstract Introduction: Providing men with prostate cancer (MPC) timely access to their health records and information (HRI) can enhance their ability to understand their condition and engage in shared medical decision making with their health care provider (HCP). The Internet is a potential means of enhancing such interactions.
Materials and methods: Two surveys were conducted at a PC support group in Victoria, BC to identify the health information needs of MPC and the ability to access their HRI. Another objective was to identify the potential role of web-enabled HRI systems at meeting these needs. Sixty-one participants (41 men… More >

Luc Valiquette¹, Francesco Montorsi², Wayne J. G. Hellstrom³, Francois Giuliano⁴, Martin Homering⁵, Terry Taylor⁶, Ian Eardley⁷

Canadian Journal of Urology, Vol.12, No.3, pp. 2687-2698, 2005

Abstract Objective: To assess success rates in ability to penetrate (Sexual Encounter Profile question 2 [SEP2]) and maintain erections to completion of intercourse (SEP3) from time of dosing to start of sexual activity in a retrospective analysis of two pivotal trials.
Methods: In two randomized, double-blind studies, men with ED for >6 months received vardenafil 5 mg, 10 mg, or 20 mg or placebo for 12-26 weeks. Patients were instructed to start sexual activity 1 hour after dosing. In this retrospective pooled analysis, patient diary questions through week 12 were analyzed, providing attempt data was recorded 0-12 hours… More >

J. Curtis Nickel¹, Sender Herschorn², Jacques Corcos², Bryan Donnelly¹, Doug Drover², Mostafa Elhilali¹, Larry Goldenberg¹, John Grantmyre², Bruno Laroche², Richard Norman¹, Bruce Piercy¹, Karen Psooy², Gary Steinhoff¹, John Trachtenberg¹, Fred Saad¹, Simon Tanguay¹

Canadian Journal of Urology, Vol.12, No.3, pp. 2677-2683, 2005

Abstract Objective: To develop the first Canadian guidelines for the management of lower urinary tract symptoms in men with benign prostatic hyperplasia (BPH).
Methods: These guidelines, developed under a mandate provided by the Canadian Urological Association (CUA), were a collaborative effort between the CUA guidelines committee and the Canadian Prostate Health Council. BPH guidelines developed by the American Urological Association, the European Association of Urology, the World Health Organization International Consultation on BPH, and similar committees from Germany, Sweden and Australia were reviewed. The committee further reviewed a systematic literature search, updated to May 2004, and systematically derived… More >